Рет қаралды 784
Listen to the Invest in Progress podcast on your chosen device: link.chtbl.com/InvestInProgre...
In this episode, Recursion’s co-founder and CEO Chris Gibson tells Scottish Mortgage’s manager Tom Slater how the firm uses cutting-edge technologies to create novel insights about biology and chemistry that can lead to potential treatments. They discuss why Recursion’s methods mean it can target rare diseases, which might not make financial sense for more traditional drug companies to explore.
Invest in Progress is a podcast brought to you by the Scottish Mortgage Team. It offers a backstage pass to the conversations between our managers and visionary leaders solving some of the world’s most complex problems. This podcast is for UK investors and existing Scottish Mortgage shareholders only.
@RecursionPharma